Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker

NCT05763511 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05763511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05763511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
May 4, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cysts, ovarian neoplasms, ovary cancer